- AdventHealth Research Institute
A new study reveals that people newly diagnosed with Type 2 diabetes face a significantly higher risk of developing aggressive cancers—including those of the liver, pancreas, and colon.
While obesity has long been linked to these cancers, the research suggests Type 2 diabetes itself may be an independent driver of cancer risk. The findings, presented at the 2025 European Congress on Obesity, analyzed data from over 23,000 people in the U.K. Biobank with new-onset Type 2 diabetes and compared them to more than 71,000 non-diabetic individuals of similar age, sex, and weight.
Over five years, cancer risk was clearly higher in the diabetes group:
- Liver cancer risk was nearly 4 times higher in men and 5 times higher in women.
- Pancreatic cancer risk rose 74% in men, nearly doubled in women.
- Colorectal cancer risk increased by more than 25% in both groups.
Lead author Owen Tipping from the University of Manchester said the link may stem from factors like inflammation, insulin resistance, or gut microbiome changes—beyond just excess weight.
Experts say more research is needed but agree the findings highlight the importance of early detection, healthy lifestyle changes, and ongoing monitoring. “This isn’t a reason to panic,” said oncologist Dr. Jack Jacoub. “It’s a reason to take action—through diet, exercise, and good blood sugar control.”
The takeaway? Type 2 diabetes may do more than disrupt blood sugar—it could quietly raise your cancer risk too.
Recent News
Alcohol, Marijuana and Type 1 Diabetes:
Whether it's a backyard barbecue, a football game or dinner with friends, alcohol and marijuana are common parts of social life. For people with Type 1 diabetes (T1D), understanding how they affect...
GLP-1 Medications: The Next Chapter in Diabetes Care
Ozempic®. Wegovy®. Zepbound®. Just a few years ago, most people had never heard these names. Today, they're among the most talked-about medications in the world. While much of the public conversation...
Q&A: Alcohol, Marijuana and Type 1 Diabetes
A Conversation with Daria Igudesman, PhD, RD, Postdoctoral Research Fellow, AdventHealth Translational Research Institute.
The Science That Moves Medicine Forward:
Have you ever wondered how breakthrough medicines are developed, how doctors determine the most effective treatments, or how healthcare continues to advance? The answer lies in clinical research—the...
Meet Jawanda Thacker: Helping Connect Today's Volunteers to Tomorrow's Medical Breakthroughs
Meet Jawanda Thacker: Helping Connect Today's Volunteers to Tomorrow's Medical Breakthroughs
Six Breakthroughs Shaping the Future of Diabetes Care
Several members of the AdventHealth Translational Research Institute (TRI) team traveled to New Orleans in June to attend the American Diabetes Association's (ADA) 2026 Scientific Sessions, where more...
AHRI Investigator Receives Prestigious American Diabetes Association Junior Faculty Development Award
The AdventHealth Translational Research Institute (TRI) is proud to announce that Dr. Justine Mucinski has received an American Diabetes Association (ADA) Junior Faculty Development Award.
Dr. Richard Pratley Featured in Nature Medicine for Breakthrough Obesity Research
Dr. Richard E. Pratley, senior investigator at the AdventHealth Translational Research Institute, has been featured as the corresponding author of a newly published study in Nature Medicine, one of...
Dr. Sparks Participates in LIMNA’s 17th Annual Metabolism and Aging Symposium
AdventHealth researcher Dr. Lauren Sparks recently had the honor of participating in LIMNA’s 17th Annual Symposium on “Metabolism and Aging” at the Olympic Museum in Lausanne
Advancing Cancer Research Closer to Home
At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...
AdventHealth Research Institute Researchers to Present at American Diabetes Association Scientific Sessions
AdventHealth Research Institute (AHRI) is proud to have a strong presence at the American Diabetes Association (ADA) 2026 Scientific Sessions, with multiple investigators and research team members...
Moving More, Managing Better
For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.